Company information
- Ticker
- CHUC
- Country
- United States
- Sector
- Consumer Staples
- Industry
- Tobacco
Charlie's Holdings Business Summary
Charlie's Holdings, Inc. (OTCQB: CHUC) generates revenue through the formulation, marketing, and global distribution of premium non-combustible nicotine and alternative alkaloid vapor products. The company operates primarily through two segments: nicotine-based products, featuring the Pacha, PACHAMAMA, and SBX brands, and alternative alkaloid/hemp-derived products, including the Metatine-based SBX line and the PINWEEL hemp extract brand. As of early 2026, the company has pivoted toward a high-growth strategy centered on its SBX product line and proprietary AI-powered, blockchain-based age-gating technology, which aims to secure first-mover advantage in the U.S. flavored vape market by ensuring 100% effective underage prevention. Charlie's Holdings competes directly with Ispire Technology Inc., 22nd Century Group, Inc., and Turning Point Brands, Inc., distinguishing itself through a clean balance sheet, high insider ownership, and a rigorous focus on FDA Premarket Tobacco Product Application (PMTA) compliance. Founded in 2014 by brothers Brandon and Ryan Stump, the company is currently led by President and Principal Executive Officer Henry Sicignano III, who previously served as the CEO of 22nd Century Group (XXII). The executive team includes Chief Operating Officer Ryan Stump, who brings a background in medical device sales and entrepreneurial growth, and Chief Financial Officer Matthew Montesano, who has managed the company’s financial operations since its inception. A critical component of the leadership’s regulatory strategy is Independent Director Dr. Edward Carmines, a world-renowned toxicology expert and former panelist for the FDA’s PMTA roundtable, who spearheads the company’s scientific and regulatory submissions. The board also features notable investors such as Michael King, with insiders collectively holding nearly 50% of the company’s equity, underscoring a strong alignment with shareholder interests as the firm pursues an uplist to a national securities exchange.